LifeWatch to Launch World's First-of-its-kind Healthcare Solution Smartphone Offering Multiple Embedded Medical Sensors and Wellness-Related Applications as well as Services (With Document)
NEUHAUSEN AM RHEINFALL, Switzerland, June 7, 2012 /PRNewswire/ --
First-ever live demonstration in Zurich on June 27, 2012
LifeWatch AG (SIX Swiss Exchange: LIFE), the leading wireless cardiac monitoring service and home sleep test provider in the U.S., announces today the launch of the world's first-of-its-kind healthcare solution Smartphone, allowing consumers self-operation of a wide range of highly valuable embedded medical sensors as well as wellness-related applications and cloud-based services. With this new technology LifeWatch will be able to expand outside its core markets, targeting new customer segments, service offerings and geographies. A comprehensive presentation and live demonstration of the solution will be given in Zurich on June 27, 2012.
You will find a PDF-version of this press release and a registration form at the end of this message.
LifeWatch has defined a number of strategic initiatives for future growth. LifeWatch's announcement today will allow the company to diverse into new services and geographies. This first-of-its-kind solution offers different layers of self-operated medical sensors, wellness-related applications as well as cloud-based services. The modular offering is targeted at health- and wellbeing-conscious consumers world-wide.
With this unique solution, for the first time, healthcare consumers and patients will be able to manage their medical condition and well-being anywhere anytime. It will empower patients and will assist in providing better care for lower costs, thus improving the use of health resources.
Emerging mobile health markets
Recent market developments have witnessed the emergence of health-dedicated mobile technologies in both developed and emerging countries. The latest mobile health market research by Frost & Sullivan indicated a market size of USD 1.5 billion in 2011 in the U.S. alone.
LifeWatch hired the leading management consulting firm McKinsey & Company to provide a full and complete Go-to-Market Analysis based on which it intends to launch the healthcare solution Smartphone world-wide.
LifeWatch: Transforming the mobile health market
Do you want to learn more about LifeWatch's latest breakthrough technology? And: Find out about the latest trends in mobile health markets? Join us for a live demonstration of the world's first-of-its-kind healthcare solution Smartphone in Zurich on June 27, 2012. Use the attached form to register now.
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home Sleep Testing of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit http://www.lifewatch.com.
Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue,""anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
Further inquiry note:
Sensus Investor and Public Relations GmbH, Zürich:
Tel +41-433665511 | Fax +41-43-366-55-12 | Email lifewatch@sensus.ch
Attachments with Announcement:
----------------------------------------------
Share this article